Flavonoids from Engineered Tomatoes Inhibit Gut Barrier Pro-inflammatory Cytokines and Chemokines, via SAPK/JNK and p38 MAPK Pathways

Frontiers in Nutrition

Volumn 4, Issue , 2017, Pages

  Tomlinson, Matthew L ^a,b   Butelli, Eugenio ^b   Martin, Cathie ^b   Carding, Simon R ^a,c  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b JOHN INNES CENTRE   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

dendritic cell; diet; epithelial; flavonoid; inflammatory bowel disease

Indexed keywords

EID: 85049518853     PISSN: None     EISSN: 2296861X     Source Type: Journal    
DOI: 10.3389/fnut.2017.00061     Document Type: Article

References (65)

1. Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis (2014) 11:130389.10.5888/pcd11.13038924742395
2. Bradbury KE, Appleby PN, Key TJ. Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Am J Clin Nutr (2014) 100:394S–8S.10.3945/ajcn.113.07135724920034
3. Liu RH. Health-promoting components of fruits and vegetables in the diet. Adv Nutr (2013) 4:384S–92S.10.3945/an.112.00351723674808
4. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 364:2392–404.10.1056/NEJMoa101429621696306
5. Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ (2014) 349:g4490.10.1136/bmj.g449025073782
6. Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity (2014) 40:833–42.10.1016/j.immuni.2014.05.014
7. Pauwels EKJ. The protective effect of the Mediterranean diet: focus on cancer and cardiovascular risk. Med Princ Pract (2011) 20:103–11.10.1159/00032119721252562
8. Tanaka T, Takahashi R. Flavonoids and asthma. Nutrients (2013) 5:2128–43.10.3390/nu5062128
9. Mann ER, Li X. Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J Gastroenterol (2014) 20:9653–64.10.3748/wjg.v20.i29.965325110405
10. Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol (2014) 20:6.10.3748/wjg.v20.i1.624415853
11. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2012) 142:46–54.e42.10.1053/j.gastro.2011.10.00122001864
12. Gómez-Gómez GJ, Masedo Á, Yela C, Martínez-Montiel Mdel P, Casís B. Current stage in inflammatory bowel disease: what is next? World J Gastroenterol (2015) 21:11282–303.10.3748/wjg.v21.i40.1128226525013
13. Hanauer SB. Review article: evolving concepts in treatment and disease modification in ulcerative colitis. Aliment Pharmacol Ther (2008) 27:15–21.10.1111/j.1365-2036.2008.03606.x18307645
14. Martin DA, Bolling BW. A review of the efficacy of dietary polyphenols in experimental models of inflammatory bowel diseases. Food Funct (2015) 6:1773–86.10.1039/C5FO00202H25986932
15. Roth S, Spalinger MR, Gottier C, Biedermann L, Zeitz J, Lang S, et al. Bilberry-derived anthocyanins modulate cytokine expression in the intestine of patients with ulcerative colitis. PLoS One (2016) 11:e0154817.10.1371/journal.pone.015481727152519
16. Dayoub O, Andriantsitohaina R, Clere N. Pleiotropic beneficial effects of epigallocatechin gallate, quercetin and delphinidin on cardiovascular diseases associated with endothelial dysfunction. Cardiovasc Hematol Agents Med Chem (2013) 11:249–64.10.2174/187152571266614030923304824617305
17. Vezza T, Rodríguez-Nogales A, Algieri F, Utrilla M, Rodriguez-Cabezas M, Galvez J. Flavonoids in inflammatory bowel disease: a review. Nutrients (2016) 8:211.10.3390/nu804021127070642
18. Cruickshank SM, English NR, Felsburg PJ, Carding SR. Characterization of colonic dendritic cells in normal and colitic mice. World J Gastroenterol (2005) 11:6338–47.10.3748/wjg.v11.i40.633816419163
19. Kmieć Z, Cyman M, Ślebioda TJ. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Adv Med Sci (2017) 62:1–16.10.1016/j.advms.2016.09.00128126697
20. Rogler G, Vavricka S, Schoepfer A, Lakatos PL. Mucosal healing and deep remission: what does it mean? World J Gastroenterol (2013) 19:7552.10.3748/wjg.v19.i43.755224282345
21. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med (2009) 206:1465–72.10.1084/jem.2008268319564350
22. Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol (2008) 14:348–53.10.3748/wjg.14.34818200658
23. Zhang Y, Butelli E, Alseekh S, Tohge T, Rallapalli G, Luo J, et al. Multi-level engineering facilitates the production of phenylpropanoid compounds in tomato. Nat Commun (2015) 6:8635.10.1038/ncomms963526497596
24. Baumgart DC, Olivier W-A, Reya T, Peritt D, Rombeau JL, Carding SR. Mechanisms of intestinal epithelial cell injury and colitis in interleukin 2 (IL2)-deficient mice. Cell Immunol (1998) 187:52–66.10.1006/cimm.1998.13079682004
25. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn’s disease. J Pathol (2003) 199:28–35.10.1002/path.1245
26. Lan J-G, Cruickshank S-M, Singh J-C-I, Farrar M, Lodge J-P-A, Felsburg P-J, et al. Different cytokine response of primary colonic epithelial cells to commensal bacteria. World J Gastroenterol (2005) 11:3375–84.10.3748/wjg.v11.i22.337515948242
27. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen T-E, Conklin LS, et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis (2009) 15:341–52.10.1002/ibd.2075318942757
28. Melgar S, Drmotova M, Rehnström E, Jansson L, Michaëlsson E. Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis. Cytokine (2006) 35:275–83.10.1016/j.cyto.2006.09.00717088072
29. Pender SL-F, Chance V, Whiting CV, Buckley M, Edwards M, Pettipher R, et al. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model. Gut (2005) 54:1114–20.10.1136/gut.2004.05277916009684
30. Inaba K, Swiggard WJ, Steinman RM, Romani N, Schuler G, Brinster C. Isolation of dendritic cells. Current Protocols in Immunology. (Unit 3.7). Hoboken, NJ, USA: John Wiley & Sons, Inc (2009) 86:I:3.7:3.7.1–3.7.19.
31. Rothaeusler K, Baumgarth N. Evaluation of intranuclear BrdU detection procedures for use in multicolor flow cytometry. Cytometry A (2006) 69A:249–59.10.1002/cyto.a.2025216538653
32. Butelli E, Titta L, Giorgio M, Mock H-P, Matros A, Peterek S, et al. Enrichment of tomato fruit with health-promoting anthocyanins by expression of select transcription factors. Nat Biotechnol (2008) 26:1301–8.10.1038/nbt.150618953354
33. Hollenbach E. Inhibition of p38 MAP kinase- and RICK/NF- B-signaling suppresses inflammatory bowel disease. FASEB J (2004) 18:1550–2.10.1096/fj.04-1642fje
34. Mitsuyama K, Suzuki A, Tomiyasu N, Tsuruta O, Kitazaki S, Takeda T, et al. Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel disease. Int J Mol Med (2006) 17:449–55.10.3892/ijmm.17.3.44916465391
35. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med (2001) 193:471–81.10.1084/jem.193.4.47111181699
36. Martin C, Butelli E, Petroni K, Tonelli C. How can research on plants contribute to promoting human health? Plant Cell (2011) 23:1685–99.10.1105/tpc.111.08327921586682
37. Yang SK, Eckmann L, Panja A, Kagnoff MF. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology (1997) 113:1214–23.10.1053/gast.1997.v113.pm93225169322516
38. Kobayashi S, Tanabe S, Sugiyama M, Konishi Y. Transepithelial transport of hesperetin and hesperidin in intestinal Caco-2 cell monolayers. Biochim Biophys Acta (2008) 1778:33–41.10.1016/j.bbamem.2007.08.02018021752
39. Steinert RE, Ditscheid B, Netzel M, Jahreis G. Absorption of black currant anthocyanins by monolayers of human intestinal epithelial Caco-2 cells mounted in ussing type chambers. J Agric Food Chem (2008) 56:4995–5001.10.1021/jf703670h18540609
40. Mullie P, Clarys P, Deriemaeker P, Hebbelinck M. Estimation of daily human intake of food flavonoids. Int J Food Sci Nutr (2008) 59:291–8.10.1080/0968763070153929317852474
41. Vogiatzoglou A, Mulligan AA, Lentjes MAH, Luben RN, Spencer JPE, Schroeter H, et al. Flavonoid intake in European adults (18 to 64 Years). PLoS One (2015) 10:e0128132.10.1371/journal.pone.012813226010916
42. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr (2000) 130:2073S–85S.10917926
43. Kim H, Kong H, Choi B, Yang Y, Kim Y, Lim MJ, et al. Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm Res (2005) 22:1499–509.10.1007/s11095-005-6250-z16132362
44. Nanua S, Zick SM, Andrade JE, Sajjan US, Burgess JR, Lukacs NW, et al. Quercetin blocks airway epithelial cell chemokine expression. Am J Respir Cell Mol Biol (2006) 35:602–10.10.1165/rcmb.2006-0149OC16794257
45. Sun M, He C, Cong Y, Liu Z. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal Immunol (2015) 8:969.10.1038/mi.2015.49
46. Nayak BN, Kaur G, Buttar HS. TNF-α modulation by natural bioactive molecules in mouse RAW 264.7 macrophage cells. J Complement Integr Med (2016) 13:1–7.10.1515/jcim-2015-002426457790
47. Noh H-J, Kim C-S, Kang J-H, Park J-Y, Choe S-Y, Hong S-M, et al. Quercetin suppresses MIP-1α-induced adipose inflammation by downregulating its receptors CCR1/CCR5 and inhibiting inflammatory signaling. J Med Food (2014) 17:550–7.10.1089/jmf.2013.291224325454
48. Yilma AN, Singh SR, Morici L, Dennis VA. Flavonoid naringenin: a potential immunomodulator for Chlamydia trachomatis inflammation. Mediators Inflamm (2013) 2013:102457.10.1155/2013/10245723766556
49. Kole A, Maloy KJ. Control of intestinal inflammation by interleukin-10. Curr Top Microbiol Immunol (2014) 380:19–38.10.1007/978-3-662-43492-5_225004812
50. Arthur JSC, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol (2013) 13:679–92.10.1038/nri349523954936
51. Feng YJ, Li YY. The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease. J Dig Dis (2011) 12:327–32.10.1111/j.1751-2980.2011.00525.x21955425
52. Yu Y, Zeng H, Lyons S, Carlson A, Merlin D, Neish AS, et al. TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. Am J Physiol (2003) 285:G282–90.10.1152/ajpgi.00503.200212702497
53. Liu X, Shah A, Gangwani MR, Silverstein PS, Fu M, Kumar A. HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors. Sci Rep (2014) 4:4450.10.1038/srep0445024658403
54. Parhar K, Ray A, Steinbrecher U, Nelson C, Salh B. The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells. Immunology (2003) 108:502–12.10.1046/j.1365-2567.2003.01603.x12667212
55. Roy PK, Rashid F, Bragg J, Ibdah JA. Role of the JNK signal transduction pathway in inflammatory bowel disease. World J Gastroenterol (2008) 14:200–2.10.3748/wjg.14.20018186555
56. Yan SR, Joseph RR, Wang J, Stadnyk AW. Differential pattern of inflammatory molecule regulation in intestinal epithelial cells stimulated with IL-1. J Immunol (2006) 177:5604–11.10.4049/jimmunol.177.8.560417015748
57. Assi K, Pillai R, Gómez-Muñoz A, Owen D, Salh B. The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis. Immunology (2006) 118:112–21.10.1111/j.1365-2567.2006.02349.x16630028
58. Romier B, Schneider Y-J, Larondelle Y, During A. Dietary polyphenols can modulate the intestinal inflammatory response. Nutr Rev (2009) 67:363–78.10.1111/j.1753-4887.2009.00210.x19566597
59. Lippert E, Karrasch T, Sun X, Allard B, Herfarth HH, Threadgill D, et al. Gnotobiotic IL-10−/−; NF-κBEGFP mice develop rapid and severe colitis following Campylobacter jejuni infection. PLoS One (2009) 4:e7413.10.1371/journal.pone.0007413
60. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature (2007) 446:557–61.10.1038/nature0569817361131
61. Singh JCI, Cruickshank SM, Newton DJ, Wakenshaw L, Graham A, Lan J, et al. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. Am J Physiol Gastrointest Liver Physiol (2004) 288:G514–24.10.1152/ajpgi.00377.2004
62. Nguyen PM, Putoczki TL, Ernst M. STAT3-activating cytokines: a therapeutic opportunity for inflammatory bowel disease? J Interferon Cytokine Res (2015) 35:340–50.10.1089/jir.2014.022525760898
63. Neufert C, Pickert G, Zheng Y, Wittkopf N, Warntjen M, Nikolaev A, et al. Activation of epithelial STAT3 regulates intestinal homeostasis. Cell Cycle (2010) 9:652–5.10.4161/cc.9.4.1061520160497
64. Farache J, Koren I, Milo I, Gurevich I, Kim KW, Zigmond E, et al. Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity (2013) 38:581–95.10.1016/j.immuni.2013.01.00923395676
65. Rescigno M. Dendritic cell-epithelial cell crosstalk in the gut. Immunol Rev (2014) 260:118–28.10.1111/imr.1218124942686